Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene, cyaC.
Bordetella pertussis adenylate cyclase (AC) toxin has the abilities to 1) enter target cells where it catalyzes cyclic AMP production and 2) lyse sheep erythrocytes, and these abilities require post-translational modification by the product of an accessory gene cyaC (Barry, E. M., Weiss, A. A., Ehrmann, E. E., Gray, M. C., Hewlett, E. L., and Goodwin, M. St. M. (1991) J. Bacteriol. 173, 720-726). In the present study, AC toxin has been purified from an organism with a mutation in cyaC, BPDE386, and evaluated for its physical and functional properties in order to determine the basis for its lack of toxin and hemolytic activities. AC toxin from BPDE386 is indistinguishable from wild-type toxin in enzymatic activity, migration on SDS-polyacrylamide gel electrophoresis, ability to bind calcium, and calcium-dependent conformational change. Although unable to elicit cAMP accumulation, AC toxin from BPDE386 exhibits binding to the surface of Jurkat cells which is comparable to that of wild-type toxin. This target cell interaction is qualitatively different, however, in that 99% of the mutant toxin remains sensitive to trypsin, whereas approximately 20% of cell-associated wild-type toxin enters a trypsin-resistant compartment. To evaluate the ability of this mutant AC toxin to function at its intracellular site of action, the cAMP-stimulated L-type calcium current in frog atrial myocytes was used. Extracellular addition of wild-type toxin results in cAMP-dependent events that include activation of calcium channels and enhancement of calcium current. In contrast, there is no response to externally applied toxin from BPDE386. When injected into the cell interior, however, the AC toxin from BPDE386 is able to produce increases in the calcium current comparable to those observed with wild-type toxin. Although AC toxin from BPDE386 is unaffected in its enzymatic activity, calcium binding, and calcium-dependent conformational change, the mutation in cyaC does result in a toxin which is able to bind to target cells but unable to elicit cAMP accumulation. In that AC toxin from BPDE386 is able to function normally when injected artificially to an intracellular site, we conclude that the disruption of cyaC produces a defect in insertion and transmembrane delivery of the catalytic domain.
Department of Medicine, University of Virginia School of Medicine, Charlottesville 22908.
E L
EL
Hewlett
M C
MC
Gray
I E
IE
Ehrmann
N J
NJ
Maloney
A S
AS
Otero
L
L
Gray
M
M
Allietta
G
G
Szabo
A A
AA
Weiss
E M
EM
Barry
D037361:Adenylate Cyclase Toxin; D000262:Adenylyl Cyclases / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D000818:Animals; D001886:Bordetella pertussis / Q000201:enzymology* / Q000235:genetics*; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D004594:Electrophysiology / Q000379:methods; D005798:Genes, Bacterial; D005809:Genes, Regulator; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006461:Hemolysis; D006801:Humans; D066298:In Vitro Techniques; D008954:Models, Biological; D011487:Protein Conformation; D011499:Protein Processing, Post-Translational; D011892:Rana catesbeiana; D011994:Recombinant Proteins / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D006377:T-Lymphocytes, Helper-Inducer; D010566:Virulence Factors, Bordetella / Q000235:genetics* / Q000302:isolation & purification / Q000494:pharmacology
D037361:Adenylate Cyclase Toxin; D015220:Calcium Channels; D011994:Recombinant Proteins; D010566:Virulence Factors, Bordetella; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D002118:Calcium